Are B vitamins a risk factor for VTE? Perhaps

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 2, 2006, Pages 309-311

  den Heijer, M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; NICOTINAMIDE; PANTOTHENIC ACID; PYRIDOXINE; RIBOFLAVIN; THIAMINE; VITAMIN B GROUP;

ARTICLE; BLOOD ANALYSIS; CONCENTRATION RESPONSE; DISEASE ASSOCIATION; HUMAN; HYPERHOMOCYSTEINEMIA; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN METABOLISM; RISK FACTOR; RISK REDUCTION; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; BLOOD; CYANOCOBALAMIN DEFICIENCY; PYRIDOXINE DEFICIENCY; REVIEW; THROMBOEMBOLISM; VEIN THROMBOSIS; VITAMIN DEFICIENCY;

HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS; VITAMIN B 12; VITAMIN B 12 DEFICIENCY; VITAMIN B 6; VITAMIN B 6 DEFICIENCY; VITAMIN B DEFICIENCY;

EID: 33645570771     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01769.x     Document Type: Article

References (14)

1. den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: A meta-analysis of published epidemiological studies. J Thromb Haemost 2005; 3: 292-9.
2. Truswell S, Milne R. The B vitamins. In: Mann J, Truswell AS, eds. Essentials of Human Nutrition. Oxford: Oxford University, 2002: 209-30.
3. den Heijer M, Bos GMJ, Gerrits WBJ, Blom HJ. Will a decrease of blood homocysteine by vitamin supplementation reduce the risk for vascular disease? Fibrinolysis 1994; 8: 91-2.
4. Den Heijer M, Blom HJ, Gerrits WB, Rosendaal FR, Haak HL, Wijermans PW, Bos GM. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet 1995; 345: 882-5.
5. Bradford Hill A. The environment and disease: Association or causation? Proc Royal Soc Med 1966; 58: 295.
6. Davey Smith G, Ebrahim S. Mendelian randomization: Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003; 32: 1-22.
7. Brattstrom L, Tengborn L, Lagerstedt C, Israelsson B, Hultberg B. Plasma homocysteine in venous thromboembolism. Haemostasis 1991; 21: 51-7.
8. Gemmati D, Previati M, Serino ML, Moratelli S, Guerra S, Capitani S, Forini E, Ballerini G, Scapoli GL. Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects. Arterioscler Thromb Vasc Biol 1999; 19: 1761-7.
9. D'Angelo A, Coppola A, Madonna P, Fermo I, Pagano A, Mazzola G, Galli L, Cerbone AM. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events. Thromb Haemost 2000; 83: 563-70.
10. Cattaneo M, Lombardi R, Lecchi A, Bucciarelli P, Mannucci PM. Low plasma levels of vitamin B(6) are independently associated with a heightened risk of deep-vein thrombosis. Circulation 2001; 104: 2442-6.
11. Quere I, Perneger TV, Zittoun J, Bellet H, Gris JC, Daures JP, Schved JF, Mercier E, Laroche JP, Dauzat M, Bounameaux H, Janbon C, de Moerloose P. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: A matched case-control study. Lancet 2002; 359: 747-52.
12. Diaz de Tuesta AM, Ribo MD, Belinchon O, Marchena PJ, Bruscas MJ, Val E, Cortes A, Nieto JA. Low levels of vitamin B12 and venous thromboembolic disease in elderly men. J Intern Med 2005; 258: 244-9.
13. Obeid R, Hakki T, Jouma M, Herrmann W. The risk of venous thromboembolism associated with the factor V Leiden mutation and low B-vitamin status. Clin Chem Lab Med 2003; 41: 1357-62.
14. Cantu C, Alonso E, Jara A, Martinez L, Rios C, Fernandez Mde L, Garcia I, Barinagarrementeria F. Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke 2004; 35: 1790-4.